Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries

BACKGROUND : Access to affordable inhaled medicines for chronic respiratory diseases (CRDs) is severely limited in low- and middle-income countries (LMICs), causing avoidable morbidity and mortality. The International Union Against Tuberculosis and Lung Disease convened a stakeholder meeting on this...

Descripción completa

Detalles Bibliográficos
Autores principales: Stolbrink, M., Chinouya, M. J., Jayasooriya, S., Nightingale, R., Evans-Hill, L., Allan, K., Allen, H., Balen, J., Beacon, T., Bissell, K., Chakaya, J., Chiang, C-Y., Cohen, M., Devereux, G., El Sony, A., Halpin, D. M. G., Hurst, J. R., Kiprop, C., Lawson, A., Macé, C., Makhanu, A., Makokha, P., Masekela, R., Meme, H., Khoo, E. M., Nantanda, R., Pasternak, S., Perrin, C., Reddel, H., Rylance, S., Schweikert, P., Were, C., Williams, S., Winders, T., Yorgancioglu, A., Marks, G. B., Mortimer, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union Against Tuberculosis and Lung Disease 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621306/
https://www.ncbi.nlm.nih.gov/pubmed/36281039
http://dx.doi.org/10.5588/ijtld.22.0270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621306/
https://www.ncbi.nlm.nih.gov/pubmed/36281039
http://dx.doi.org/10.5588/ijtld.22.0270

Ejemplares similares